Seppic opens a brand new lab for fermentation biotechnologies within the USA

The Air Liquide group firm is accelerating its investments in biotechnologies. Seppic has opened a laboratory devoted to fermentation on the group’s Innovation Campus Delaware, the place Seppic’s American Buyer Technical Service Heart has been primarily based since 2007.

Fermentation is a course of traditionally used to provide and protect meals. Utilized to the cosmetics and well being markets, this expertise permits the manufacturing of biobased substances with restricted affect on the atmosphere and biodiversity, whereas minimizing affect on land use.

“With new gear and in depth know-how, the purpose of this laboratory will probably be to develop new substances that mix efficacy with a response to societal challenges within the cosmetics and well being fields, in keeping with the corporate’s strategy to dedicated innovation,” mentioned the corporate in an announcement.

With this alternative of location, Seppic goals to learn from robust synergies with Air Liquide Group R&D actions on the Campus, in addition to with the dynamic American Analysis ecosystem within the discipline of biotechnologies.

“Following the opening in 2024 of recent Analysis services at our Castres website in France, Seppic continues to take a position sooner or later with this laboratory in the USA. It would allow us to proceed innovating for the efficiency of our substances by addressing the wants of our markets,” mentioned Hannes Moeller, Chief Government Officer of Seppic.